Enteric Disease Testing Market Drivers: Rising Incidence of Gastrointestinal Infections Worldwide

The Enteric Disease Testing Market is witnessing steady expansion due to the increasing burden of gastrointestinal infections, rising awareness about food safety, and growing adoption of advanced diagnostic technologies. According to industry analysis, Enteric Disease Testing Market is projected to grow from US$ 4.00 billion in 2025 to US$ 5.47 billion by 2034, registering a CAGR of 3.54% during 2026–2034. Enteric diseases, caused by bacteria, viruses, and parasites, remain a major global health concern, especially in developing regions where sanitation challenges persist. The rising demand for early detection and rapid diagnostics is accelerating investments in laboratory infrastructure and molecular testing platforms.

Healthcare systems worldwide are prioritizing infection control and disease surveillance, which is significantly contributing to the demand for enteric disease testing solutions. The integration of automation, multiplex testing, and point-of-care diagnostics is transforming how gastrointestinal infections are detected and managed. Public health initiatives, increasing research funding, and government policies supporting disease prevention further strengthen the market outlook.

Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00004384

Market Drivers

Rising Global Burden of Gastrointestinal Infections

One of the most influential drivers of the Enteric Disease Testing Market is the rising prevalence of gastrointestinal infections caused by pathogens such as Salmonella, E. coli, Campylobacter, Shigella, and norovirus. These infections continue to affect millions of people annually and contribute to significant healthcare costs and productivity losses. Increasing international travel, urbanization, and changing food consumption patterns are elevating the risk of disease transmission, which in turn increases the demand for reliable diagnostic testing.

Developing nations are particularly vulnerable to enteric diseases due to inadequate sanitation infrastructure, unsafe drinking water, and limited access to healthcare. Governments and public health organizations are implementing programs to improve disease detection and outbreak control, boosting the adoption of advanced testing solutions. The growing emphasis on disease surveillance is expected to remain a major growth catalyst throughout the forecast period.

Increasing Awareness of Food Safety and Hygiene

The rise in foodborne illness outbreaks has heightened awareness among consumers, food manufacturers, and regulatory authorities. Food safety regulations are becoming more stringent across the globe, prompting food processing companies and laboratories to adopt rapid and accurate diagnostic tests. Regulatory bodies now require routine screening and quality checks to ensure public safety, creating a strong demand for enteric disease testing kits and instruments.

Food exports and international trade have further amplified the need for standardized testing protocols. Countries importing food products often require strict pathogen testing to prevent cross-border contamination. This global emphasis on food safety is expected to sustain steady market growth.

Technological Advancements in Diagnostic Testing

Rapid technological innovation is transforming the enteric disease testing landscape. Molecular diagnostics, polymerase chain reaction (PCR), next-generation sequencing (NGS), and immunoassays have significantly improved the speed and accuracy of pathogen detection. Multiplex testing, which allows simultaneous detection of multiple pathogens in a single test, is gaining popularity due to its efficiency and cost-effectiveness.

Automation and digitalization are also improving laboratory workflow efficiency, reducing turnaround times, and minimizing human error. Point-of-care testing devices are enabling faster diagnosis in remote and resource-limited settings, further driving market expansion. As healthcare providers increasingly adopt advanced diagnostic platforms, the market is expected to witness sustained growth.

Growing Demand for Point-of-Care Testing

The shift toward decentralized healthcare and rapid diagnostics has boosted the adoption of point-of-care enteric disease testing solutions. These tests provide quick results, enabling healthcare professionals to initiate timely treatment and prevent disease spread. Point-of-care testing is particularly valuable in emergency settings, rural healthcare facilities, and outbreak situations where rapid diagnosis is critical.

The COVID-19 pandemic highlighted the importance of rapid diagnostic capabilities, leading to increased investments in testing infrastructure. This trend continues to influence the enteric disease testing market, as healthcare providers prioritize preparedness for future infectious disease outbreaks.

Expanding Healthcare Infrastructure in Emerging Economies

Emerging economies in Asia-Pacific, Latin America, and the Middle East are experiencing rapid healthcare infrastructure development. Governments are investing heavily in laboratory networks, diagnostic centers, and healthcare facilities to improve disease management and public health outcomes. These investments are increasing access to diagnostic services and creating new opportunities for market players.

Rising disposable incomes and growing health awareness are also encouraging individuals to seek early diagnosis and treatment. As healthcare access improves, demand for enteric disease testing solutions is expected to grow significantly in these regions.

Market Trends

Adoption of Multiplex and Syndromic Testing Panels

Syndromic testing panels that detect multiple gastrointestinal pathogens simultaneously are becoming increasingly popular. These panels offer faster diagnosis, reduce the need for multiple tests, and improve patient outcomes. Laboratories are increasingly adopting multiplex PCR-based systems due to their efficiency and reliability.

Increasing Use of Automation and AI

Automation and artificial intelligence are being integrated into diagnostic workflows to enhance efficiency and accuracy. AI-powered analytics help interpret complex test results and identify patterns, improving disease surveillance and outbreak detection. This trend is expected to shape the future of enteric disease testing.

Growth of Home-Based Testing

The demand for home-based diagnostic kits is rising as consumers seek convenient and accessible healthcare solutions. Self-testing kits for gastrointestinal infections are gaining traction, especially in developed markets, and are expected to contribute to long-term market growth.

Competitive Landscape and Key Players

The Enteric Disease Testing Market is moderately competitive, with several global and regional players focusing on product innovation, partnerships, and strategic acquisitions. Companies are investing in research and development to introduce advanced diagnostic solutions and expand their market presence.

Top Players in the Enteric Disease Testing Market:

• Abbott Laboratories
• Thermo Fisher Scientific Inc.
• bioMérieux SA
• QIAGEN N.V.
• Danaher Corporation
• BD (Becton, Dickinson and Company)
• F. Hoffmann-La Roche Ltd.
• Bio-Rad Laboratories, Inc.
• Meridian Bioscience, Inc.
• Hologic, Inc.

These companies are actively launching new products and expanding their global footprint to strengthen their competitive position.

Regional Insights

North America currently holds a significant share of the market due to advanced healthcare infrastructure, high awareness levels, and strong regulatory frameworks. Europe follows closely, supported by stringent food safety regulations and growing investments in diagnostic research.

The Asia-Pacific region is expected to witness the fastest growth during the forecast period due to increasing healthcare investments, rising disease burden, and expanding diagnostic capabilities. Countries such as China and India are focusing on improving disease surveillance and laboratory networks, creating lucrative opportunities for market players.

Future Outlook

The Enteric Disease Testing Market is expected to experience steady growth through 2034, driven by technological advancements, increasing disease prevalence, and rising awareness about food safety and hygiene. The growing adoption of molecular diagnostics, point-of-care testing, and multiplex assays will continue to shape the market landscape. As healthcare systems worldwide prioritize early disease detection and prevention, the demand for enteric disease testing solutions will remain strong.

About Us

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us

Ankit Mathur | The Insight Partners
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in : Korean | German | Japanese | French | Chinese | Italian | Spanish